Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells.

AUTOR(ES)

Drancourt, M

RESUMO

Hemostasis abnormalities have been described in patients with Mediterranean spotted fever and Rocky Mountain spotted fever. Evidence of the activation of the fibrinolytic system has been obtained in both diseases. After experimental Rocky Mountain spotted fever, an elevated level of fibrinogen was found in parallel with the activation of the fibrinolytic system and transient elevation of the tissue-type plasminogen activator. Later protein is mainly synthesized by endothelial cells. The ability to culture human endothelial cells in vitro provides a unique system to study the secretion of tissue-type plasminogen activator and of plasminogen activator inhibitor after rickettsial infection. Human vascular endothelial cells derived from the umbilical vein, when infected with Rickettsia conorii or Rickettsia rickettsii, secreted as much tissue-type plasminogen activator as control cells. The activity of plasminogen activator inhibitor however, was higher in the supernatants of infected cells than in those of control cells. This rickettsia-induced imbalance of the tissue-type plasminogen activator-inhibitor pair was a very early event after in vitro infection. The involvement of this system during Mediterranean spotted fever and Rocky Mountain spotted fever remains to be demonstrated.

Documentos Relacionados

• Variant tissue-type plasminogen activator (PLAT) cDNA obtained from human endothelial cells
• alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.
• Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
• Nucleotide sequence of the tissue-type plasminogen activator cDNA from human fetal lung cells.
• Origins of the specificity of tissue-type plasminogen activator.